DIGIFAB: payments to doctors
Payments that named DIGIFAB as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 190
- Transactions
- 345
- Average per transaction
- $3,098
The per-transaction average — $3,098 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 190 providers the average total is $5,626, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| BTG International, Inc. | $1,009,917 | 94.5% |
| BTG International Inc. | $59,039 | 5.5% |